102 related articles for article (PubMed ID: 12770692)
1. Pharmacological characterization of recombinant bovine alpha3beta4 neuronal nicotinic receptors stably expressed in HEK 293 cells.
Free RB; von Fischer ND; Boyd RT; McKay DB
Neurosci Lett; 2003 Jun; 343(3):180-4. PubMed ID: 12770692
[TBL] [Abstract][Full Text] [Related]
2. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
[TBL] [Abstract][Full Text] [Related]
3. Receptor protection studies comparing recombinant and native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha3beta4* nicotinic receptors.
Free RB; Kaser DJ; Boyd RT; McKay DB
Neurosci Lett; 2006 Jan; 392(1-2):135-9. PubMed ID: 16198480
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.
Stauderman KA; Mahaffy LS; Akong M; Veliçelebi G; Chavez-Noriega LE; Crona JH; Johnson EC; Elliott KJ; Gillespie A; Reid RT; Adams P; Harpold MM; Corey-Naeve J
J Pharmacol Exp Ther; 1998 Feb; 284(2):777-89. PubMed ID: 9454827
[TBL] [Abstract][Full Text] [Related]
5. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
6. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
7. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
Parker MJ; Beck A; Luetje CW
Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
[TBL] [Abstract][Full Text] [Related]
8. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
Eaton JB; Peng JH; Schroeder KM; George AA; Fryer JD; Krishnan C; Buhlman L; Kuo YP; Steinlein O; Lukas RJ
Mol Pharmacol; 2003 Dec; 64(6):1283-94. PubMed ID: 14645658
[TBL] [Abstract][Full Text] [Related]
10. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
Vainio PJ; Tuominen RK
Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
[TBL] [Abstract][Full Text] [Related]
11. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
Free RB; McKay DB
Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
Chavez-Noriega LE; Crona JH; Washburn MS; Urrutia A; Elliott KJ; Johnson EC
J Pharmacol Exp Ther; 1997 Jan; 280(1):346-56. PubMed ID: 8996215
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
Tachikawa E; Mizuma K; Kudo K; Kashimoto T; Yamato S; Ohta S
Neurosci Lett; 2001 Oct; 312(3):161-4. PubMed ID: 11602335
[TBL] [Abstract][Full Text] [Related]
15. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
[TBL] [Abstract][Full Text] [Related]
16. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
18. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
19. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine.
Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW
J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686
[TBL] [Abstract][Full Text] [Related]
20. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs.
Abdrakhmanova GR; Damaj MI; Carroll FI; Martin BR
Mol Pharmacol; 2006 Jun; 69(6):1945-52. PubMed ID: 16505153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
